TTM
70.7%
YoY change
+0.24pp
Trough year (2023)
62.4%
Peak year (2015)
80.3%
Latest annual
70.2%
Gross Margin history chart for AbbVie (ABBV) from 2009 to 2025
Latest: 70.2%
Gross Margin change chart for AbbVie (ABBV) from 2009 to 2025
Latest: +0.24pp
Gross Margin history table for AbbVie (ABBV) from 2009 to 2025
| 2025 | 70.2% | +0.24pp | ||
| 2024 | 70.0% | +7.58pp | ||
| 2023 | 62.4% | -7.59pp | ||
| 2022 | 70.0% | +1.05pp | ||
| 2021 | 69.0% | +2.55pp | ||
| 2020 | 66.4% | -11.23pp | ||
| 2019 | 77.6% | +1.20pp | ||
| 2018 | 76.4% | +1.39pp | ||
| 2017 | 75.0% | -2.20pp | ||
| 2016 | 77.2% | -3.07pp | ||
| 2015 | 80.3% | +2.49pp | ||
| 2014 | 77.8% | +2.21pp | ||
| 2013 | 75.6% | +0.15pp | ||
| 2012 | 75.5% | +2.07pp | ||
| 2011 | 73.4% | +0.86pp | ||
| 2010 | 72.5% | +1.09pp | ||
| 2009 | 71.5% | — |
- 202570.2%+0.24pp
- 202470.0%+7.58pp
- 202362.4%-7.59pp
- 202270.0%+1.05pp
- 202169.0%+2.55pp
- 202066.4%-11.23pp
- 201977.6%+1.20pp
- 201876.4%+1.39pp
- 201775.0%-2.20pp
- 201677.2%-3.07pp
- 201580.3%+2.49pp
- 201477.8%+2.21pp
- 201375.6%+0.15pp
- 201275.5%+2.07pp
- 201173.4%+0.86pp
- 201072.5%+1.09pp
- 200971.5%—
Gross Margin values are taken from AbbVie's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Gross Margin at AbbVie (ABBV)
According to AbbVie's latest reported financial statements, the company's latest reported gross margin is 70.7%. Gross margin is gross profit divided by revenue, expressed as a percentage. It shows how much of each sales dollar survives the direct cost of goods sold — before operating expenses, interest, and taxes. A higher gross margin generally signals pricing power and production efficiency. Margins are most meaningful compared against sector peers and a company's own history.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, AbbVie (ABBV) reported gross margin of 70.24% – expanded 0.2 percentage points year-over-year.
2015 marks the peak gross margin at 80.31%, with the historical low of 62.42% recorded in 2023.
AbbVie Gross Margin by Year
AbbVie Gross Margin 2025: 70.2%
In 2025, AbbVie reported gross margin of 70.24%, expanded 0.2 percentage points from 2024.
AbbVie Gross Margin 2024: 70.0%
AbbVie gross margin in 2024 was 69.99%, expanded 7.6 percentage points from 2023.
AbbVie Gross Margin 2023: 62.4%
2023's gross margin for AbbVie came in at 62.42%, contracted 7.6 percentage points from 2022. This figure represents the lowest annual value in the available history.
AbbVie Gross Margin 2022: 70.0%
AbbVie posted gross margin of 70.00% in 2022, expanded 1.0 percentage points from 2021.
AbbVie Gross Margin 2021: 69.0%
AbbVie gross margin in 2021 was 68.96%.
See more financial history for AbbVie (ABBV).
Sector peers by Gross Margin
Healthcare peers of AbbVie (ABBV), ranked by their latest gross margin
| 83.5% | |
| 81.8% | |
| 81.7% | |
| 75.9% | |
| 71.5% | |
| 70.0% | |
| 39.4% | |
| 18.8% |
- 83.5%
- 81.8%
- 81.7%
- 75.9%
- 71.5%
Frequently asked questions
AbbVie (ABBV) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation